Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.
about
DNA vaccine for cancer immunotherapyTrial watch: Naked and vectored DNA-based anticancer vaccinesDNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model.A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance
P2860
Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct T cell activation via C ...... nce for the control of tumors.
@en
Direct T cell activation via C ...... nce for the control of tumors.
@nl
type
label
Direct T cell activation via C ...... nce for the control of tumors.
@en
Direct T cell activation via C ...... nce for the control of tumors.
@nl
prefLabel
Direct T cell activation via C ...... nce for the control of tumors.
@en
Direct T cell activation via C ...... nce for the control of tumors.
@nl
P2093
P2860
P1433
P1476
Direct T cell activation via C ...... nce for the control of tumors.
@en
P2093
Chien-Fu Hung
Janson Trieu
Liangmei He
Liwen Song
Ruey-Shyang Soong
Sung Yong Lee
Ya-Chea Tsai
P2860
P304
P356
10.1371/JOURNAL.PONE.0093162
P407
P577
2014-03-24T00:00:00Z